GlassScriptPhysician profile
Amanda L Mowrer
NPI 1003341074
$5,401.63
in general payments reported to CMS, 2019-2025
10 companies · $4,702 in 2025
The $4,702 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.61 · 2022: $208 · 2024: $392 · 2025: $4,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,119 · Consulting Fee: $1,820 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.90 |
| Consulting Fee | $1,820.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
| Travel and Lodging | $254.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,551.56 | 2021-2025 | Xifaxan, Trulance |
| Gilead Sciences, INC. | $1,235.43 | 2025 | Livdelzi |
| Ipsen Biopharmaceuticals, INC | $1,151.66 | 2025 | Iqirvo |
| Abbvie INC. | $680.41 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $270.00 | 2024-2025 | Terlivaz |
| Exact Sciences Corporation | $198.13 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Madrigal Pharmaceuticals | $144.67 | 2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $121.60 | 2025 | Voquezna |
| Pharmacosmos Therapeutics INC. | $32.44 | 2024 | Monoferric |
| Medtronic, INC. | $15.73 | 2025 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mowrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.